Home › Funds › MILLENNIUM MANAGEMENT LLC › JAZZ
MILLENNIUM MANAGEMENT LLC position in JAZZ
JAZZ PHARMACEUTICALS PLC SHS USD · Health Care
MILLENNIUM MANAGEMENT LLC reported holding 763,880 shares of JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD) in its Q2 2026 13F filing — a position valued at US$184.1M, representing 0.24% of its reported portfolio and ranking #43 among its reported holdings. MILLENNIUM MANAGEMENT LLC has disclosed JAZZ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How MILLENNIUM MANAGEMENT LLC's JAZZ position evolved
MILLENNIUM MANAGEMENT LLC first disclosed a stake in JAZZ in Q3 2023 at 30,000 shares (US$3.9M). The position peaked in Q2 2026 at 763,880 shares, worth US$184.1M. Across 12 filings, MILLENNIUM MANAGEMENT LLC increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 763,880 shares valued at US$184.1M — an increase of 738,480 shares quarter over quarter.. Notable position changes include a 26422% increase in Q2 2024 (shares rose 4% over the following quarter), a 976% increase in Q3 2025 (shares rose 29% over the following quarter), a 2907% increase in Q2 2026 (shares fell 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 30.00K | $3.88M | New |
| Q4 2023 | 30.00K | $3.69M | Hold |
| Q1 2024 | 1.70K | $204.71K | Reduce |
| Q2 2024 | 450.87K | $48.12M | Add |
| Q3 2024 | 20.00K | $2.23M | Reduce |
| Q4 2024 | 20.20K | $2.49M | Add |
| Q1 2025 | 21.45K | $2.66M | Add |
| Q2 2025 | 25.00K | $2.65M | Add |
| Q3 2025 | 269.11K | $35.47M | Add |
| Q4 2025 | 15.50K | $2.63M | Reduce |
| Q1 2026 | 25.40K | $4.80M | Add |
| Q2 2026 | 763.88K | $184.07M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About JAZZ and 13F data
JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD) is a Health Care company. 43 other funds we track also report a position in JAZZ — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$394.8M), GMT CAPITAL CORP (US$109.3M), Boston Trust Walden Corp (US$106.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding JAZZ
- FULLER & THALER ASSET MANAGEMENT, INC. 1.64M sh · $394.84M · Q2 2026
- GMT CAPITAL CORP 453.50K sh · $109.28M · Q2 2026
- Boston Trust Walden Corp 443.12K sh · $106.78M · Q2 2026
- SYSTEMATIC FINANCIAL MANAGEMENT LP 378.71K sh · $91.26M · Q2 2026
- Sofinnova Investments, Inc. 365.34K sh · $88.04M · Q2 2026
More on MILLENNIUM MANAGEMENT LLC
FAQ
How long has MILLENNIUM MANAGEMENT LLC held JAZZ?
MILLENNIUM MANAGEMENT LLC has disclosed JAZZ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is MILLENNIUM MANAGEMENT LLC's current position in JAZZ?
As of Q2 2026, MILLENNIUM MANAGEMENT LLC holds 763.88K shares of JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD), valued at $184.07M, representing 0.24% of its reported portfolio and ranking #43.
Has MILLENNIUM MANAGEMENT LLC been buying or selling JAZZ?
In the latest 13F filing (Q2 2026), MILLENNIUM MANAGEMENT LLC increased its position in JAZZ. The position peaked in Q2 2026 at 763.88K shares.
Which other funds hold JAZZ?
Other major institutional holders of JAZZ include FULLER & THALER ASSET MANAGEMENT, INC., GMT CAPITAL CORP, Boston Trust Walden Corp, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.